- Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients
- Study Shows EUFLEXXA(R) Patients Report Significant Improvements In Osteoarthritis Of The Knee Pain Over A Six Month Period
- Access To Psychological Support And Self-Management Courses Could Ease The Emotional Burden Of Arthritis/Rheumatism, Survey Says
- Chronic Disease Keeping Older Australians Out Of The Workforce
- ACTEMRA(R) (tocilizumab) Studies To Be Featured At American College Of Rheumatology Annual Scientific Meeting
- Pfizer Reaches Agreements In Principle To Resolve Litigation Involving Its NSAID Pain Medications - $894 Million Settlements
- Rheumatoid Arthritis Rising Among Women
- First International Guidelines For Treatment Of Psoriatic Arthritis Developed
- Psoriatic Arthritis: First International Guidelines For Treatment
- Study Shows ENBREL(R) (etanercept) More Effective Than A DMARD In The Treatment Of Symptoms Of Ankylosing Spondylitis Patients
- CIMZIA(R) (Certolizumab Pegol) Provides Rapid And Sustained Relief From Signs And Symptoms Of Rheumatoid Arthritis For Two Years
- ACTEMRA (R) (tocilizumab) Significantly Reduced Signs And Symptoms Of Rheumatoid Arthritis In Patients Who Failed Prior Treatments
- Tociluzumab Quick And Effective For Rheumatoid Arthritis Patients
- More Patients With Early Erosive Rheumatoid Arthritis Treated With ORENCIA(R) And Methotrexate Achieved DAS28 (CRP)-Defined Remission Versus MTX Alone
- University Of Kentucky Launches Clinical Outcomes-Based Educational Initiative To Reinforce Rheumatoid Arthritis (RA) Standards Of Care
- Cimzia(R) Study Shows Rapid Reduction Of Symptoms And Inhibition Of Joint Damage Progression In RA
- Predicting Depression In People With Rheumatoid Arthritis
- Fibromyalgia Can No Longer Be Called The 'Invisible' Syndrome
- MRI Can Eliminate Unnecessary Surgery For Children With Suspected Musculosketal Infections
- Alternative Dosing Should Be Considered Due To Wide Variability In Rheumatoid Arthritis Drug
- Destruction Of Joints By Arthritis: Genetic Disorder Sheds Light On Enzyme's Role In Bone Metabolism
- New Therapeutic Target Identified For Rheumatoid Arthritis
- Rheumatoid Arthritis Breakthrough
- New Data Points To Long Lasting Beneficial Effects Of CEL-SCI's Rheumatoid Arthritis Vaccine
- New One-Stop Diabetic Rheumatology Clinic Is First In UK
- Rheumatoid Arthritis - Cimzia(R) Studies Show Significant Clinical Benefits For Mono- And Combination Therapy
- Key US Patent Granted On Antibodies Against GM-CSF To Treat Inflammatory Disorders (Rheumatoid Arthritis)
- Better Management More Important Than New Drugs For Arthritis
- Results From The First And Largest Collaborative Study Confirm Role Of Enbrel® In Psoriatic Arthritis
- Clinicians Debate Use Of Arthroscopy In Patients With Osteoarthritis
- Forest Laboratories, Inc. And Cypress Bioscience, Inc. Announce Positive Results Of Phase III Study Of Milnacipran For The Management Of Fibromyalgia
- Third Osteoarthritis Study This Year Reveals Pycnogenol® Lowers Inflammatory Marker CRP
- CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649
- MabThera Inhibits The Destruction Of Joints In Patients With Early Rheumatoid Arthritis
- Phase III Study Showed Rituxan® Decreased The Progression Of Joint Damage In Patients With Early Rheumatoid Arthritis (RA)
- Phase III Study Showed Rituxan® Decreased The Progression Of Joint Damage In Patients With Early Rheumatoid Arthritis
- ESBATech's Antibody Fragment Enters Phase I/IIa Clinical Development In Osteoarthritis With The Potential For Disease-Modifying Activity
- Cause Of Cartilage Degeneration In Osteoarthritis Discovered By Scripps Research Scientists
- Gender Difference In Severity Of Rheumatoid Arthritis
- Novel Drugs Selectively Target Pathway Important In Rheumatoid Arthritis
- Greater Quadriceps Strength May Benefit Those With Knee Osteoarthritis
- Anakinra For Rheumatoid Arthritis: A Modest Benefit With Some Risk, Study Suggests
- Discovery Of A Key Protein Regulator Of Inflammation And Cell Death
- Gene Therapy Demonstrates Benefit In Patients With Rheumatoid Arthritis
- Patients With Rheumatoid Arthritis Benefit From Gene Therapy
- Exercise Does Not Appear To Raise Damage To Joints
- Current And Emerging Therapies Have No Advantage Over Enbrel In Reducing The Signs And Symptoms Of Rheumatoid Arthritis
- Callisto Pharmaceuticals Redirects Atiprimod Clinical Development To Treat Rheumatoid Arthritis
- Progression Slowed And Symptoms Of Knee Osteoarthritis Relieved By Chondroitin
- Rheumatoid Arthritis: Study Provides First Evidence Of Clinical Response To Gene Therapy
- UCB's Meeting With U.S. FDA Defines Path Forward For Cimzia(R) In Rheumatoid Arthritis.
- Nutra Pharma Subsidiary, ReceptoPharm, Files Patent Application For Novel Treatment Of Arthritis Using RPI-78
- Psoriatic Arthritis Treatment of Ustekinumab Effective, Study Suggests
- FDA Approves First Gout Drug For 40 Years
- Type Of Rheumatoid Arthritis Medication May Be Associated With Increased Risk For Shingles
- New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years
- New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
- New NICE Guidelines Encourage Wider Use Of Anti-CCP Testing In Rheumatoid Arthritis
- Osteoarthritis Worsens With Excess Weight
- Osteoarthritis Worsens With Excess Weight
- Most Complementary Medicines Have No Effect For People With Rheumatoid Arthritis; Picture More Hopeful For Osteoarthritis Patients
- Ustekinumab In The Treatment Of Psoriatic Arthritis: Investigational Study Published
- FDA Approves First Gout Drug For 40 Years
- How Inflammatory Disease Causes Fatigue
- In Arthritis Patients, Inhibiting Proteins May Prevent Cartilage Breakdown
- New Treatment Against Osteoarthritis: Orthokine Therapy Highly Effective Against Knee Arthritis After Two Years
- New NICE Guidelines To Help Thousands Of People With Rheumatoid Arthritis
- Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis
- Ultrasound Changes Care Of Some Patients With Rheumatic Conditions
- Chlamydia May Play Role In A Type Of Arthritis
- A Phase IIb Study Testing The Combination Of Methotrexate And CF101 In Rheumatoid Arthritis Patients Failed To Achieve Primary Efficacy Endpoint
- There Are More Than 100 Reasons To See A Rheumatologist
- Supplements No Better Than Placebo In Slowing Cartilage Loss In Knees Of Osteoarthritis Patients
- Two-Year Data Reinforce Effect Of ACTEMRA(R) (tocilizumab) In Inhibiting Progression Of Joint Damage And Improving Physical Function In Arthritis
- Breakthrough Treatment For Rheumatoid Arthritis Offers New Hope To Patients
- Treating Gum Disease Helps Rheumatoid Arthritis Sufferers
- Can Inflammatory Arthritis Be 'Worse Than Death'?
- Association Between Rheumatoid Arthritis And Poor Sleep In Women
- Exercise Improves Functional And Psycological Ability And Reduces Steroid Need In Rheumatoid Arthritis
- New Treatment Strategy Offers Hope To RA Patients Who Failed All Other Therapies
- The Beneficial Effects Of Pregnancy And Childbearing On Arthritic Conditions May Be More Long-Term Than Previously Understood
- Disclosing Feelings May Help The Course Of Rheumatoid Arthritis
- Cimzia(R), The Only PEGylated Anti-TNF, Recommended For Approval In The EU For Rheumatoid Arthritis
- Discovery Of New Trigger For Chronic Inflammation In Rheumatoid Arthritis
- Nearly Half Of Rheumatoid Arthritis Sufferers Feel Early Treatment Would Have Given Them More Independence
- Osteoarthritis A Major Consequence Of Obesity Epidemic, Claims Charity In New Report
- Using Ultrasound To Detect Early Signs Of Osteoarthritis
- Disease Markers That Will Aid Arthritis Research
- Rheumatoid Arthritis Is Worse In Poorer Countries
- GlaxoSmithKline And Genmab Announce Top-line Results For Ofatumumab In Rheumatoid Arthritis
- Link Between Pain In Rheumatoid Arthritis Patients And Depression/Inflammation
- Addition Of A TNF Antagonist Better Option For Patients With Early Rheumatoid Arthritis Who Have Poor Response To Methotrexate
- Tissue Engineering Could Yield Cure, Prevention For Osteoarthritis
- Studies Show Dramatic Decline In Rheumatoid Vasculitis In US Veterans
- Compliance With NICE Recommendations For The Management Of Rheumatoid Arthritis (RA) Now Made Easier
- Breakthrough Genetic Test Helps Doctors Assess Risk Of Developing Psoriatic Arthritis (PsA)
- Biologics For Rheumatoid Arthritis Work, But Which Is Best?
- New Biologic Drug Is Effective Against Rheumatoid Arthritis
- Insufficient Evidence To Recommend TENS For Osteoarthritis
- Trial Raises Doubts Over Alternative Pain Therapy For Arthritis
- Magnetic And Copper Bracelets Ineffective Against Pain Of Arthritis, Controlled Study
- Phase III Study Showed Two Years Of ACTEMRA(R) (tocilizumab) Inhibited Progression Of Joint Damage And Improved Disease Remission
- New SIMPONI(TM) Data Show Long-Term Efficacy In Treatment Of Rheumatoid Arthritis
- Lubris, Biomodels Report On Potential New Therapy For Osteoarthritis
- Updated Data From Randomized Controlled Phase II Study Evaluating Oral Apremilast In Psoriatic Arthritis Demonstrates Sustained Response At Six Months
- FDA Approves New Test To Aid In The Diagnosis Of Rheumatoid Arthritis
- Growing Cartilage From Stem Cells
- Tocilizumab Shows Sustained Efficacy In Rheumatoid Arthritis
- Link Between Pain Thresholds, Inflammation And Sleep Problems In Arthritis Patients
- Anti-tumor Necrosis Factor Treatment Does Not Increase Cancer Risk In Rheumatoid Arthritis Patients, Study Finds
- Tai Chi Exercise Reduces Knee Osteoarthritis Pain In The Elderly
- New Tool To Accelerate Discovery Of Autoimmune Disease Mechanisms And Therapies
- Judgement In Favour Of NICE On Judicial Review Of Abatacept For Rheumatoid Arthritis Guidance
- Adeona Announces Publication Of Results Of 160 Patient Phase 2 Clinical Trial Of Oral DnaJP1 For Rheumatoid Arthritis
- Osteoarthritis Increases Aggregate Health Care Expenditures By $186 Billion Annually
- Strength training, self-management improve outcomes for knee osteoarthritis
- FDA Approves ACTEMRA(R) (tocilizumab) For The Treatment Of Moderately To Severely Active Rheumatoid Arthritis
- Genetic Research Related To Disabling Form Of Arthritis
- NICE Draft Guidance Set To Help People With Rheumatoid Arthritis
- Arthritis: Environmental exposure to hairspray, lipstick, pollution, can trigger autoimmune diseases
- Rheumatoid Arthritis Halted: Researcher Invents Nontoxic Drug That Forces Hyperactive Immune Cells To Die
- Biomarker Could Help Doctors Tailor Treatment For Rheumatoid Arthritis
- Walking Linked To Eased Osteoarthritis
- NICE Consults On Draft Recommendations For Treating Rheumatoid Arthritis After Treatment With A TNF Inhibitor Has Failed
- Potential new target for treating rheumatoid arthritis
- Rheumatoid Arthritis Linked To Vitamin D Deficiency
- Rheumatology Specialist Nurses: £100 Million "added Value" To NHS Per Year, Wales
- Discovery That Collagen Can Be Floppy Could Mean New Treatments For Heart Disease
- Out-of-Pocket Costs Put Arthritis Drugs Out Of Reach For Some
- Rheumatoid arthritis patients and doctors differ on disease severity assessment
- New Criteria Proposed For Diagnosing Fibromyalgia Suggests No Longer Focusing On Tender Points
- Rheumatoid arthritis incidence on the rise in women
- Rheumatoid Arthritis Incidence On The Rise In Women
- Pro-Pointer, Inc. Introduces New Supplement For Arthritic And Inflammatory Conditions
- Enbrel® (etanercept) Recommended In UK For Adults With Active And Progressive Psoriatic Arthritis By NICE
- Pain Suffered Daily By Almost Three Quarters Of Women With Rheumatoid Arthritis
- Almost three quarters of women with rheumatoid arthritis worldwide suffer pain daily
- Gut-residing bacteria trigger arthritis in genetically susceptible individuals
- Partners grieve rheumatoid arthritis diagnosis as much as patients
- Women Who Consume Large Amounts Of Tea Have Increased Risk Of Rheumatoid Arthritis
- VBL Presents Positive Preclinical Data On Immune Modulator In Rheumatoid Arthritis At EULAR Annual Meeting
- Rheumatoid Arthritis And Risk Of Heart Attack
- Confirmation That Vitamin D Deficiency Common Across A Range Of Rheumatic Conditions
- Partners Grieve Rheumatoid Arthritis Diagnosis As Much As Patients
- RA Patients In Rich Countries Are Three Times More Likely To Receive Biologic Treatment Than Those In Poor Countries
- In RA Patients, Expression Of Certain Transporter Proteins May Predict Resistance To Drug Therapy
- Lodotra (Modified-Release Prednisone) Significantly Reduces Morning Stiffness In Rheumatoid Arthritis
- Arthritis Relief - Gastrointestinal Damage Less Likely With Celecoxib Than Diclofenac/Omeprazole (CONDOR Study)
- Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program
- Early and aggressive arthritis treatment recommended, based on results of 11-year trial
- Aerobic exercise safe and effective for rheumatoid arthritis patients, experts say
- A Recommendation For Early And Aggressive Arthritis Treatment - Results From 11-Year Trial
- Aerobic Exercise Safe And Effective For Rheumatoid Arthritis Patients
- Subchondral Bone Changes Contribute To Cartilage Damage And Loss
- NICE Recommends Treatments For Rheumatoid Arthritis After The Failure Of A TNF Inhibitor
- Surprising Find May Yield New Avenue Of Treatment For Painful Herniated Discs
- Eisai And Morphotek(R), Inc. Announce Initiation Of MORAb-022 Study In Europe For The Treatment Of Inflammatory Disease
- Draft NICE Guidance Recommends Tocilizumab For Rheumatoid Arthritis
- Majority of Ontarians suffering from rheumatoid arthritis not receiving needed speciality care, study finds
- Failure To Diagnose Type Of Arthritis Costs Society Dear Experts Tell UK Government
- Trial Shows Glucosamine No Better Than Placebo For Lower Back Pain
- Addex Drug Candidate Effective In Osteoarthritis Pain Model
- Unigene Reports Continuation Of Phase III Study Of Oral Calcitonin In Osteoarthritis Patients
- Horizon Pharma, Inc. Announces Results Of Phase 3 Study Of LODOTRA® Demonstrate 12-Month Sustained Efficacy And Safety In Rheumatoid Arthritis
- Alcohol reduces the severity of rheumatoid arthritis, study finds
- New Rheumatoid Arthritis Criteria To Stave Off Disabling Disease For Thousands Of People
- Acupuncture not superior to sham acupuncture in knee osteoarthritis, study finds
- Acupuncture Not Superior To Sham Acupuncture In Knee Osteoarthritis
- Insertional calcific achilles tendinopathy
- Synovial Fluid From Arthritic Joints Found To Contain 'Rotten Eggs' Gas
- Rheumatoid arthritis signaling protein reverses Alzheimer's disease in mouse model
- NICE Recommends Treatments For Rheumatoid Arthritis
- NICE Improves Access To Drug Treatments For Psoriatic Arthritis
- Novel model for rheumatoid arthritis research
- Molecular gatekeeper of arthritis identified: Removal of key protein leads to initiation of disease
- Animal Model Of Rheumatoid Arthritis (KRN-CTM) Deepens Understanding Of The Disease
- Molecular Gatekeeper Of Arthritis Identified
- Krystexxa (pegloticase) Approved For Treatment Of Gout
- Forty Four Percent Of Surveyed Rheumatologists Who Expect To Prescribe Arzerra For The Treatment Of Arthritis Say They Will Prescribe Arzerra
- Special Turmeric Extract Benefits Osteoarthritis Patients
- new Rheumatology /pod clinic
- Tarsa Therapeutics And Unigene Present Preclinical Data Suggesting Calcitonin May Have Utility In Therapy For The Treatment Of Osteoarthritis
- DMARDs, Glucocorticoids, And Biologics Equally Effective For Rheumatoid Arthritis
- Tanezumab Found To Reduce Osteoarthritis Knee Pain In Phase II Study
- Tanezumab Alleviates Osteoarthritis Pain So Well That Some Patients Overuse Their Diseased Joints
- NICE Unable To Recommend Golimumab For The Treatment Of Psoriatic Arthritis
- Juvenile arthritis: Etanercept helps restore normal growth in children with, study finds
- FDA Approves Cymbalta® For The Management Of Chronic Musculoskeletal Pain
- Rapid And Long-term Clinical Responses Observed In Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab Pegol)
- Rheumatology Mythbusters: Thirteen Things About Rheumatic Diseases That Just Aren't True
- Vitamin D May Not Benefit Knee Osteoarthritis Sufferers
- The Number Of People With Gout Continues To Rise
- New Magnetic Resonance Imaging (MRI) Data Show Efficacy Of SIMPONI® In Treatment Of Rheumatoid Arthritis
- Abbott Presents Data Exploring Relationship Of Physical Function To Inflammation And Structural Damage In RA
- People With Rheumatoid Arthritis And Lupus Often Skip Their Medications
- Anti-TNF Biologic Cimzia Treatment Can Benefit RA Patients With Long-standing Disease And Exposure To Multiple Previous Therapies Including Biologics
- Arthritis May Be Treated With Umbilical Cord Cells
- Early Diagnosis of Rheumatoid Arthritis Crucial to Positive Outcomes for Patients
- Osteoarthritis May Be Prevented By Light Exercise
- Genetic link found between spinal arthritis and inflammatory bowel disease
- New Treatment For Early To Mid-Stage Osteoarthritis May Provide Better Precision During Surgery
- Enbrel Outpaces Humira In The First Three Lines Of Treatment In Newly Diagnosed Rheumatoid Arthritis Patients
- TreatmentTrends®: European Gout Study Highlights Current Treatment Patterns And Unmet Need For New Gout Therapies Among Rheumatologists
- By 2019, The Acute Gout Drug Market Will Triple In Size While The Chronic Gout Drug Market Will Reach $1.83 Billion
- Seek Early Diagnosis And Treatment For Arthritis, Rheumatologists Urge
- Smoking Behind More Than A Third Of Severe Rheumatoid Arthritis Cases
- Garlic could protect against hip osteoarthritis
- Clinical Practitioners Not Adhering To Evidence-based Guidelines For Osteoarthritis
- Lifetime risk of adult rheumatoid arthritis determined
- Researchers Determine Lifetime Risk Of Adult Rheumatoid Arthritis
- Uric acid may increase likelihood of severe osteoarthritis
- Fostamatinib shown to be safe but not effective in rheumatoid arthritis patients unresponsive to biologic agents
- Depression Risk In Rheumatoid Arthritis Patients Increased By Low Socioeconomic Status
- In Rheumatoid Arthritis Patients Unresponsive To Biologic Agents
- Many rheumatoid arthritis patients not getting recommended drugs, researchers find
- Unexpected New Mechanism Behind Rheumatoid Arthritis
- Obesity and knee osteoarthritis shorten healthy years of life
- Unexpected New Mechanism Behind Rheumatoid Arthritis
- Rheumatoid Arthritis Researchers Redefine Remission
- Joint pain in children: Is it just a sore knee, or could it be juvenile idiopathic arthritis?
- The Disease Modifying Effect Of Chondroitin Sulphate In Patients With Knee Osteoarthritis Has Been Confirmed By MRI
- Safety In The Kitchen For Rheumatoid Arthritis Sufferers
- Rituximab combined with a TNF inhibitor and methotrexate shows no safety signal in rheumatoid arthritis treatment, study finds
- Engineered protein has potential for new anti-inflamatory treatment
- Knee Arthritis Symptoms In Older Adults Adversely Affected By Depression
- Depression can worsen knee arthritis symptoms in older adults
- New clinical practice guidelines developed for juvenile idiopathic arthritis
- Personalised Therapies For Inflammation Created By Researchers Able To Mimic Body's Own Healing Potential
- Injectable Gel Could Spell Relief For Arthritis Sufferers
- FDA Approves Actemra To Treat Rare Form Of Juvenile Arthritis
- Rheumatoid Arthritis Patients Treated With Cimzia(R) (Certolizumab Pegol) report Positive Results
- NICE Recommends Golimumab For The Treatment Of Psoriatic Arthritis
- Adults with arthritis suffer with poorer health related quality of life
- Tofacitinib Effective In Helping Rheumatoid Arthritis Patients, Trial Results Find
- Cimzia® (Certolizumab Pegol) Data Showed Rapid Improvement In Rheumatoid Arthritis Patients
- Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
- Cimzia(R) (Certolizumab Pegol) Data Showed Broad And Rapid Relief From Burden Of Symptoms In Rheumatoid Arthritis Patients
- 'Simponi'® (Golimumab) Available In The UK For The Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis
- NICE Provisionally Recommends New Drug For Rheumatoid Arthritis
- FDA Approves ACTEMRA(R) (Tocilizumab) For The Treatment Of Systemic Juvenile Idiopathic Arthritis (SJIA)
- Rheumatoid Arthritis Patients Treated With Cimzia(R) (Certolizumab Pegol) report Positive Results
- NICE Recommends Golimumab For The Treatment Of Psoriatic Arthritis
- Cimzia® (Certolizumab Pegol) Data Showed Rapid Improvement In Rheumatoid Arthritis Patients
- Pfizer Announces Top-Line Results Of Final Two Pivotal Phase 3 Trials Of Tofacitinib (CP-690,550) In Patients With Active Rheumatoid Arthritis
- In Diagnosis Of Juvenile Inflammatory Arthritis In Children, Sonography Complements Physical Exam
- Cimzia(R) (Certolizumab Pegol) Data Showed Broad And Rapid Relief From Burden Of Symptoms In Rheumatoid Arthritis Patients
- 'Simponi'® (Golimumab) Available In The UK For The Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis
- NICE Provisionally Recommends New Drug For Rheumatoid Arthritis
- Rheumatoid Arthritis Drug Simponi (golimumab) Gets Provisional Approval By NICE, UK
- Novel ACR Hybrid Score In Rheumatoid Arthritis Applied For The First Time To Data From The RAPID 1 Study With Cimzia(R) (Certolizumab Pegol)